Multiple Myeloma

Learn about the newest therapies, interventions, and clinical research on multiple myeloma (MM). Cancer Nursing Today provides the latest clinical data and insights on screening for early detection, COVID-19 vaccine responses in patients with MM, and more. From treatment developments for relapsed/refractory MM and imaging techniques to the latest in CAR T-cell therapy, explore the latest outcomes in MM.

Adding Isatuximab to Carfilzomib and Dexamethasone Improves Depth of Response in R/R MM
Isatuximab plus carfilzomib and dexamethasone led to a higher MRD negativity rate and more complete responses (CR) than carfilzomib and dexamethasone in patients with relapsed/refractory (R/R) multiple myeloma (MM), according to a recent study. Thomas Martin, MD, of the University of California, San Francisco, and colleagues conducted the study, which was a subanalysis of the randomized, open label, multicenter, phase III IKEMA study. Investigators published the results in Blood Advances. ...
Advertisement

Latest News

Advertisement

Knowledge Hubs

GI Cancer
GI Cancer

Conference Highlights

June 16, 2022


Advertisement
Advertisement
Popular Stories